Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,747 | -120,459 | -88,853 | -60,200 | -59,513 |
| Depreciation Amortization | 2,590 | -2,305 | -352 | 609 | 913 |
| Accounts payable and accrued liabilities | 2,208 | 2,067 | -1,217 | 626 | 1,644 |
| Other Working Capital | 232,723 | 100,694 | 89,288 | 6,443 | 688 |
| Other Operating Activity | 50,338 | 19,311 | 19,432 | 7,195 | 7,521 |
| Operating Cash Flow | $175,112 | $-692 | $18,298 | $-45,327 | $-48,747 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,747 | -6,349 | -359 | -133 | -449 |
| Purchase Of Investment | -902,128 | -362,120 | -283,372 | -89,719 | -35,031 |
| Sale Of Investment | 655,000 | 418,000 | 81,000 | 70,000 | 48,500 |
| Other Investing Activity | 15 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-258,860 | $49,531 | $-202,731 | $-19,852 | $13,020 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 59,572 | 52,938 | 170,621 | 43,515 | 561 |
| Other Financing Activity | -149 | -50 | -738 | 69,216 | -27 |
| Financing Cash Flow | $59,423 | $52,888 | $169,883 | $112,731 | $534 |
| Beginning Cash Position | 156,710 | 54,983 | 69,533 | 21,981 | 57,174 |
| End Cash Position | 132,385 | 156,710 | 54,983 | 69,533 | 21,981 |
| Net Cash Flow | $-24,325 | $101,727 | $-14,550 | $47,552 | $-35,193 |
| Free Cash Flow | |||||
| Operating Cash Flow | 175,112 | -692 | 18,298 | -45,327 | -48,747 |
| Capital Expenditure | -11,747 | -6,349 | -359 | -133 | -449 |
| Free Cash Flow | 163,365 | -7,041 | 17,939 | -45,460 | -49,196 |